Financial Calendar

Event
Financial year
Event
Results published
Timing

Full-year preliminary results early September

Recent / upcoming dates

Our preliminary results for the year ending 30-Jun-18 were released on 10-Sep-18. These are available for download on the Reports & presentations page and in the RNS section.

Timing

Interim results early March

Recent / upcoming dates

Our interim results for the half-year ending 31-Dec-17 were released on 05-Mar-18. These are available for download on the Reports & presentations page and in the RNS section.

Event
Pre-close trading updates
Timing

Full year early-mid July

Recent / upcoming dates

Our pre-close trading update for the year ending 30-Jun-18 was released on 12-Jul-18 and can be found in the RNS section.

Timing

Half year mid January

Recent / upcoming dates

Our pre-close trading update for the half year ending 31-Dec-17 was released on 5-Jan-18 and can be found in the RNS section.

Event
AGM
Timing

Early November

Recent / upcoming dates

Our 2018 AGM will be held on 06-Nov-18 at 14:00 at our Cambridge offices.

The AGM notice and documentation are available for download on the Reports & presentations page.

 

 

Event
Dividends
Timing

Final dividend record date November, paid late November / early December (subject to shareholder approval).

Recent / upcoming dates

A final dividend of 8.58p per share for the year ending 30-Jun-18 has been proposed by the Board. If approved at the 2018 AGM, it will be paid on 30-Nov-18 to shareholders on the register at close of business on 09-Nov-18 (the associated ex-dividend date for this will be 08-Nov-18).

Timing

Interim dividend record date March, paid April

Recent / upcoming dates

An interim dividend of 3.42p per share for the half year ending 31-Dec-17 paid was paid on 12-Apr-18 to shareholders on the register at close of business on 16-Mar-17 (the associated ex-dividend date was 15-Mar-17).

About Abcam

Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research.

Read more +

Abcam Products

As an innovator in reagents and tools, Abcam offers highly validated binders and assays to address important targets in critical biological pathways.

Read more +

Investor Information

Abcam is listed on the AIM market of the London Stock Exchange under the ticker ABC, and our investors' centre includes a range of information on our company, including our news, financial reports and investor contacts

Read more +

Abcam News

We provide updates on our commercial and financial progress through regular press releases which can be accessed through the Company's media centre.

Read more +